Form 4 for GLUE Monte Rosa Therapeutics, Inc.
Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-23 · accession 0001193125-26-066955 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-24 | 2026-02-23 | GLUE | Janku Filip | Chief Medical Off | S - Sale | $19.50 | -9,189 | 65.8K | -12% | -$179.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | S | D | 9,189 | $19.50 | 65,837 | D | — | — |